fanta.bio Sample: CNhs11971
17919 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1234 / 16608 (7.4%) | 412 / 166080 (0.2%) | −324.0 | −324.0 | 29.95 |
| HIF1A SRX11007095 | HK-2 Kidney | 2466 / 16608 (14.8%) | 862 / 166080 (0.5%) | −324.0 | −324.0 | 28.61 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1827 / 16608 (11.0%) | 702 / 166080 (0.4%) | −324.0 | −324.0 | 26.03 |
| HIF1A SRX20663235 | HK-2 Kidney | 537 / 16608 (3.2%) | 245 / 166080 (0.1%) | −324.0 | −324.0 | 21.92 |
| TP53 SRX19538279 | Osteoblasts Bone | 542 / 16608 (3.3%) | 261 / 166080 (0.2%) | −324.0 | −324.0 | 20.77 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1656 / 16608 (10.0%) | 798 / 166080 (0.5%) | −324.0 | −324.0 | 20.75 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2378 / 16608 (14.3%) | 1170 / 166080 (0.7%) | −324.0 | −324.0 | 20.32 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2296 / 16608 (13.8%) | 1158 / 166080 (0.7%) | −324.0 | −324.0 | 19.83 |
| SCML2 SRX644728 | 293 Kidney | 1346 / 16608 (8.1%) | 807 / 166080 (0.5%) | −324.0 | −324.0 | 16.68 |
| BRD4 SRX9419935 | BT-474 Breast | 3953 / 16608 (23.8%) | 2639 / 166080 (1.6%) | −324.0 | −324.0 | 14.98 |
| MED1 SRX9419945 | BT-474 Breast | 3903 / 16608 (23.5%) | 2661 / 166080 (1.6%) | −324.0 | −324.0 | 14.67 |
| MED1 SRX9419944 | BT-474 Breast | 3817 / 16608 (23.0%) | 2608 / 166080 (1.6%) | −324.0 | −324.0 | 14.64 |
| BRD4 SRX9419937 | BT-474 Breast | 3914 / 16608 (23.6%) | 2697 / 166080 (1.6%) | −324.0 | −324.0 | 14.51 |
| MYH11 SRX265221 | ME-1 Blood | 869 / 16608 (5.2%) | 609 / 166080 (0.4%) | −324.0 | −324.0 | 14.27 |
| FOXP1 SRX736067 | LNCAP Prostate | 1735 / 16608 (10.4%) | 1224 / 166080 (0.7%) | −324.0 | −324.0 | 14.17 |
| BRD4 SRX9419938 | BT-474 Breast | 3954 / 16608 (23.8%) | 2795 / 166080 (1.7%) | −324.0 | −324.0 | 14.15 |
| BRD4 SRX9419936 | BT-474 Breast | 3961 / 16608 (23.8%) | 2815 / 166080 (1.7%) | −324.0 | −324.0 | 14.07 |
| MED1 SRX9419946 | BT-474 Breast | 3957 / 16608 (23.8%) | 2834 / 166080 (1.7%) | −324.0 | −324.0 | 13.96 |
| MED1 SRX9419947 | BT-474 Breast | 3822 / 16608 (23.0%) | 2770 / 166080 (1.7%) | −324.0 | −324.0 | 13.80 |
| EZH2 SRX2146136 | LNCAP Prostate | 8228 / 16608 (49.5%) | 7918 / 166080 (4.8%) | −324.0 | −324.0 | 10.39 |
| BRD4 SRX736201 | 90-8TL Neural | 6270 / 16608 (37.8%) | 6507 / 166080 (3.9%) | −324.0 | −324.0 | 9.64 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 800 / 16608 (4.8%) | 918 / 166080 (0.6%) | −324.0 | −324.0 | 8.71 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1797 / 16608 (10.8%) | 2718 / 166080 (1.6%) | −324.0 | −324.0 | 6.61 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1509 / 16608 (9.1%) | 3604 / 166080 (2.2%) | −324.0 | −324.0 | 4.19 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1943 / 16608 (11.7%) | 4930 / 166080 (3.0%) | −324.0 | −324.0 | 3.94 |
| AGO2 SRX4708039 | Hep G2 Liver | 2204 / 16608 (13.3%) | 7251 / 166080 (4.4%) | −324.0 | −324.0 | 3.04 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2428 / 16608 (14.6%) | 9353 / 166080 (5.6%) | −324.0 | −324.0 | 2.60 |
| 5-mC SRX882970 | LNCAP Prostate | 3340 / 16608 (20.1%) | 14734 / 166080 (8.9%) | −324.0 | −324.0 | 2.27 |
| 5-mC SRX882968 | LNCAP Prostate | 3273 / 16608 (19.7%) | 14611 / 166080 (8.8%) | −324.0 | −324.0 | 2.24 |
| RUNX1 SRX2513054 | 293 Kidney | 3723 / 16608 (22.4%) | 17265 / 166080 (10.4%) | −324.0 | −324.0 | 2.16 |
| PBX4 SRX2731658 | PC-3 Prostate | 710 / 16608 (4.3%) | 26320 / 166080 (15.8%) | −324.0 | −324.0 | 0.27 |
| FOS SRX150478 | MCF 10A Breast | 505 / 16608 (3.0%) | 20035 / 166080 (12.1%) | −324.0 | −324.0 | 0.25 |
| YAP1 SRX757325 | H2052 Lung | 509 / 16608 (3.1%) | 20351 / 166080 (12.3%) | −324.0 | −324.0 | 0.25 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 455 / 16608 (2.7%) | 18613 / 166080 (11.2%) | −324.0 | −324.0 | 0.24 |
| FOS SRX150477 | MCF 10A Breast | 474 / 16608 (2.9%) | 19580 / 166080 (11.8%) | −324.0 | −324.0 | 0.24 |
| YAP1 SRX757326 | H2052 Lung | 422 / 16608 (2.5%) | 18276 / 166080 (11.0%) | −324.0 | −324.0 | 0.23 |
| 5-mC SRX882965 | LNCAP Prostate | 2678 / 16608 (16.1%) | 11397 / 166080 (6.9%) | −319.2 | −316.3 | 2.35 |
| CIC SRX13262055 | Astrocytes Neural | 3372 / 16608 (20.3%) | 16262 / 166080 (9.8%) | −317.6 | −314.7 | 2.07 |
| TP53 SRX19538274 | U2OS Bone | 440 / 16608 (2.6%) | 168 / 166080 (0.1%) | −313.1 | −310.2 | 26.19 |
| FOXA1 SRX4815198 | MCF-7 Breast | 823 / 16608 (5.0%) | 23872 / 166080 (14.4%) | −312.1 | −309.2 | 0.34 |
| TP53 SRX19538268 | U2OS Bone | 437 / 16608 (2.6%) | 179 / 166080 (0.1%) | −304.8 | −301.9 | 24.41 |
| TP53 SRX19538276 | U2OS Bone | 435 / 16608 (2.6%) | 180 / 166080 (0.1%) | −302.5 | −299.6 | 24.17 |
| FOS SRX4192880 | MCF 10A Breast | 362 / 16608 (2.2%) | 15864 / 166080 (9.6%) | −300.7 | −297.8 | 0.23 |
| FOXA1 SRX4815197 | MCF-7 Breast | 597 / 16608 (3.6%) | 19525 / 166080 (11.8%) | −287.8 | −284.9 | 0.31 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 695 / 16608 (4.2%) | 926 / 166080 (0.6%) | −287.3 | −284.5 | 7.51 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 607 / 16608 (3.7%) | 646 / 166080 (0.4%) | −287.1 | −284.2 | 9.40 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 911 / 16608 (5.5%) | 24125 / 166080 (14.5%) | −279.6 | −276.8 | 0.38 |
| TP53 SRX19538280 | Osteoblasts Bone | 416 / 16608 (2.5%) | 200 / 166080 (0.1%) | −276.2 | −273.3 | 20.80 |
| FOXA1 SRX176862 | MCF-7 Breast | 285 / 16608 (1.7%) | 13654 / 166080 (8.2%) | −273.9 | −271.1 | 0.21 |
| TP53 SRX19538267 | U2OS Bone | 391 / 16608 (2.4%) | 159 / 166080 (0.1%) | −273.2 | −270.4 | 24.59 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1963 / 16608 (11.8%) | 7563 / 166080 (4.6%) | −273.0 | −270.2 | 2.60 |
| TP53 SRX19538281 | Osteoblasts Bone | 446 / 16608 (2.7%) | 283 / 166080 (0.2%) | −268.3 | −265.5 | 15.76 |
| TP53 SRX19538273 | U2OS Bone | 386 / 16608 (2.3%) | 160 / 166080 (0.1%) | −268.2 | −265.4 | 24.13 |
| FOXA1 SRX176863 | MCF-7 Breast | 267 / 16608 (1.6%) | 13058 / 166080 (7.9%) | −265.1 | −262.3 | 0.20 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 278 / 16608 (1.7%) | 13267 / 166080 (8.0%) | −265.1 | −262.3 | 0.21 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1568 / 16608 (9.4%) | 5313 / 166080 (3.2%) | −264.2 | −261.4 | 2.95 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 661 / 16608 (4.0%) | 933 / 166080 (0.6%) | −262.8 | −260.0 | 7.08 |
| TP53 SRX19538275 | U2OS Bone | 389 / 16608 (2.3%) | 177 / 166080 (0.1%) | −262.8 | −260.0 | 21.98 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 938 / 16608 (5.6%) | 23897 / 166080 (14.4%) | −261.4 | −258.7 | 0.39 |
| GATA3 SRX190239 | MCF-7 Breast | 353 / 16608 (2.1%) | 14544 / 166080 (8.8%) | −261.2 | −258.4 | 0.24 |
| FOS SRX150517 | MCF 10A Breast | 426 / 16608 (2.6%) | 15812 / 166080 (9.5%) | −260.4 | −257.6 | 0.27 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 415 / 16608 (2.5%) | 237 / 166080 (0.1%) | −259.7 | −257.0 | 17.51 |
| FOS SRX150476 | MCF 10A Breast | 431 / 16608 (2.6%) | 15867 / 166080 (9.6%) | −259.4 | −256.7 | 0.27 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 585 / 16608 (3.5%) | 699 / 166080 (0.4%) | −258.6 | −255.9 | 8.37 |
| Epitope tags SRX10549776 | K-562 Blood | 1512 / 16608 (9.1%) | 5066 / 166080 (3.1%) | −258.6 | −255.8 | 2.98 |
| FOXA1 SRX3931044 | MCF-7 Breast | 567 / 16608 (3.4%) | 18070 / 166080 (10.9%) | −257.2 | −254.5 | 0.31 |
| JUNB SRX8488088 | SUM 229PE Breast | 502 / 16608 (3.0%) | 16981 / 166080 (10.2%) | −256.5 | −253.8 | 0.30 |
| TRP47 SRX4548329 | THP-1 Blood | 2794 / 16608 (16.8%) | 13481 / 166080 (8.1%) | −256.4 | −253.7 | 2.07 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1031 / 16608 (6.2%) | 25006 / 166080 (15.1%) | −254.6 | −252.0 | 0.41 |
| TP53 SRX19538269 | U2OS Bone | 479 / 16608 (2.9%) | 408 / 166080 (0.2%) | −253.8 | −251.1 | 11.74 |
| FOXA1 SRX1161177 | MCF-7 Breast | 223 / 16608 (1.3%) | 11839 / 166080 (7.1%) | −252.7 | −250.0 | 0.19 |
| IRF3 SRX11453858 | Hep G2 Liver | 326 / 16608 (2.0%) | 88 / 166080 (0.1%) | −252.6 | −250.0 | 37.05 |
| ESR1 SRX371478 | MCF-7 Breast | 314 / 16608 (1.9%) | 13515 / 166080 (8.1%) | −250.3 | −247.7 | 0.23 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 314 / 16608 (1.9%) | 13511 / 166080 (8.1%) | −250.2 | −247.5 | 0.23 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 276 / 16608 (1.7%) | 12777 / 166080 (7.7%) | −249.4 | −246.7 | 0.22 |
| AGO2 SRX6783957 | Hep G2 Liver | 1372 / 16608 (8.3%) | 4394 / 166080 (2.6%) | −249.2 | −246.6 | 3.12 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2008 / 16608 (12.1%) | 8320 / 166080 (5.0%) | −245.6 | −242.9 | 2.41 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1812 / 16608 (10.9%) | 7068 / 166080 (4.3%) | −245.5 | −242.9 | 2.56 |
| JUN SRX17561461 | LPS141 Adipocyte | 370 / 16608 (2.2%) | 14371 / 166080 (8.7%) | −245.1 | −242.5 | 0.26 |
| ESR1 SRX7624157 | MCF-7 Breast | 731 / 16608 (4.4%) | 20245 / 166080 (12.2%) | −245.0 | −242.4 | 0.36 |
| SREBF2 SRX5359048 | HCC70 Breast | 1857 / 16608 (11.2%) | 7399 / 166080 (4.5%) | −242.7 | −240.1 | 2.51 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1150 / 16608 (6.9%) | 26225 / 166080 (15.8%) | −242.0 | −239.4 | 0.44 |
| GATA3 SRX190194 | SK-N-SH Neural | 670 / 16608 (4.0%) | 19179 / 166080 (11.5%) | −241.2 | −238.6 | 0.35 |
| FOXA1 SRX371482 | MCF-7 Breast | 380 / 16608 (2.3%) | 14397 / 166080 (8.7%) | −240.2 | −237.6 | 0.26 |
| FOXA1 SRX371483 | MCF-7 Breast | 280 / 16608 (1.7%) | 12571 / 166080 (7.6%) | −239.7 | −237.1 | 0.22 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 683 / 16608 (4.1%) | 19270 / 166080 (11.6%) | −238.0 | −235.4 | 0.35 |
| AGO2 SRX6783958 | Hep G2 Liver | 1335 / 16608 (8.0%) | 4339 / 166080 (2.6%) | −237.3 | −234.7 | 3.08 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 299 / 16608 (1.8%) | 12843 / 166080 (7.7%) | −236.8 | −234.2 | 0.23 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 166 / 16608 (1.0%) | 10226 / 166080 (6.2%) | −236.8 | −234.2 | 0.16 |
| TLE3 SRX4815191 | MCF-7 Breast | 233 / 16608 (1.4%) | 11543 / 166080 (7.0%) | −235.1 | −232.5 | 0.20 |
| AR SRX1067071 | LHSAR Prostate | 549 / 16608 (3.3%) | 17022 / 166080 (10.2%) | −233.8 | −231.2 | 0.32 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 960 / 16608 (5.8%) | 23219 / 166080 (14.0%) | −233.4 | −230.8 | 0.41 |
| TP53 SRX19538270 | U2OS Bone | 449 / 16608 (2.7%) | 400 / 166080 (0.2%) | −232.7 | −230.2 | 11.22 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2059 / 16608 (12.4%) | 8896 / 166080 (5.4%) | −232.6 | −230.0 | 2.31 |
| BMI1 SRX7196721 | SF8628 Neural | 1866 / 16608 (11.2%) | 7639 / 166080 (4.6%) | −232.2 | −229.6 | 2.44 |
| FOXA1 SRX1161173 | MCF-7 Breast | 177 / 16608 (1.1%) | 10335 / 166080 (6.2%) | −232.2 | −229.6 | 0.17 |
| FOXA1 SRX371481 | MCF-7 Breast | 266 / 16608 (1.6%) | 12080 / 166080 (7.3%) | −231.8 | −229.3 | 0.22 |
| ESR1 SRX371469 | MCF-7 Breast | 262 / 16608 (1.6%) | 11986 / 166080 (7.2%) | −231.2 | −228.7 | 0.22 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 863 / 16608 (5.2%) | 21692 / 166080 (13.1%) | −230.0 | −227.5 | 0.40 |
| ESR1 SRX20282961 | MCF-7 Breast | 338 / 16608 (2.0%) | 13349 / 166080 (8.0%) | −230.0 | −227.5 | 0.25 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 616 / 16608 (3.7%) | 17912 / 166080 (10.8%) | −228.6 | −226.0 | 0.34 |
| FOXA1 SRX1161176 | MCF-7 Breast | 235 / 16608 (1.4%) | 11372 / 166080 (6.8%) | −227.9 | −225.3 | 0.21 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 271 / 16608 (1.6%) | 12033 / 166080 (7.2%) | −227.0 | −224.5 | 0.23 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 555 / 16608 (3.3%) | 16887 / 166080 (10.2%) | −226.7 | −224.2 | 0.33 |
| MITF SRX1555436 | 501A Epidermis | 2091 / 16608 (12.6%) | 9230 / 166080 (5.6%) | −226.6 | −224.1 | 2.27 |
| SMARCA4 SRX5212366 | Mel270 Others | 359 / 16608 (2.2%) | 13592 / 166080 (8.2%) | −225.9 | −223.4 | 0.26 |
| KAT6A SRX20971022 | Fibroblasts Others | 292 / 16608 (1.8%) | 80 / 166080 (0.0%) | −225.5 | −223.1 | 36.50 |
| ESR1 SRX371471 | ZR-75-1 Breast | 283 / 16608 (1.7%) | 12195 / 166080 (7.3%) | −224.8 | −222.4 | 0.23 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 240 / 16608 (1.4%) | 11385 / 166080 (6.9%) | −224.8 | −222.3 | 0.21 |
| JUNB SRX8488073 | SUM 229PE Breast | 541 / 16608 (3.3%) | 16598 / 166080 (10.0%) | −224.7 | −222.2 | 0.33 |
| ESR1 SRX7624156 | MCF-7 Breast | 451 / 16608 (2.7%) | 15120 / 166080 (9.1%) | −224.5 | −222.0 | 0.30 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 638 / 16608 (3.8%) | 18118 / 166080 (10.9%) | −224.4 | −222.0 | 0.35 |
| FOS SRX4192879 | MCF 10A Breast | 298 / 16608 (1.8%) | 12449 / 166080 (7.5%) | −224.1 | −221.6 | 0.24 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1695 / 16608 (10.2%) | 6707 / 166080 (4.0%) | −223.1 | −220.6 | 2.53 |
| ESR1 SRX4367193 | MCF-7 Breast | 989 / 16608 (6.0%) | 23246 / 166080 (14.0%) | −222.8 | −220.4 | 0.43 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2056 / 16608 (12.4%) | 9077 / 166080 (5.5%) | −222.4 | −219.9 | 2.27 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 223 / 16608 (1.3%) | 10968 / 166080 (6.6%) | −221.9 | −219.5 | 0.20 |
| ESR1 SRX371479 | MCF-7 Breast | 238 / 16608 (1.4%) | 11254 / 166080 (6.8%) | −221.7 | −219.2 | 0.21 |
| GATA3 SRX176864 | MCF-7 Breast | 167 / 16608 (1.0%) | 9800 / 166080 (5.9%) | −220.4 | −217.9 | 0.17 |
| ESR1 SRX371470 | ZR-75-1 Breast | 233 / 16608 (1.4%) | 11118 / 166080 (6.7%) | −220.3 | −217.8 | 0.21 |
| SMARCA2 SRX8119677 | MeT-5A Others | 463 / 16608 (2.8%) | 15168 / 166080 (9.1%) | −219.8 | −217.4 | 0.31 |
| RUNX1 SRX2014504 | Jurkat Blood | 2527 / 16608 (15.2%) | 12431 / 166080 (7.5%) | −219.0 | −216.6 | 2.03 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 222 / 16608 (1.3%) | 10851 / 166080 (6.5%) | −218.5 | −216.1 | 0.20 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 501 / 16608 (3.0%) | 15731 / 166080 (9.5%) | −218.0 | −215.5 | 0.32 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 573 / 16608 (3.5%) | 16867 / 166080 (10.2%) | −217.5 | −215.1 | 0.34 |
| YAP1 SRX5718140 | 293 Kidney | 494 / 16608 (3.0%) | 15592 / 166080 (9.4%) | −217.2 | −214.8 | 0.32 |
| AR SRX1067070 | LHSAR Prostate | 739 / 16608 (4.4%) | 19397 / 166080 (11.7%) | −217.0 | −214.6 | 0.38 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1938 / 16608 (11.7%) | 8396 / 166080 (5.1%) | −216.9 | −214.5 | 2.31 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 708 / 16608 (4.3%) | 18925 / 166080 (11.4%) | −216.8 | −214.4 | 0.37 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 235 / 16608 (1.4%) | 11055 / 166080 (6.7%) | −216.8 | −214.3 | 0.21 |
| BRD1 SRX286203 | RKO Digestive tract | 1240 / 16608 (7.5%) | 4073 / 166080 (2.5%) | −216.5 | −214.1 | 3.04 |
| FOXA1 SRX1161175 | MCF-7 Breast | 180 / 16608 (1.1%) | 9946 / 166080 (6.0%) | −216.0 | −213.6 | 0.18 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 226 / 16608 (1.4%) | 10849 / 166080 (6.5%) | −215.7 | −213.3 | 0.21 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 232 / 16608 (1.4%) | 10950 / 166080 (6.6%) | −215.1 | −212.8 | 0.21 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 267 / 16608 (1.6%) | 11594 / 166080 (7.0%) | −214.5 | −212.1 | 0.23 |
| KAT7 SRX101303 | RKO Digestive tract | 1403 / 16608 (8.4%) | 5054 / 166080 (3.0%) | −214.1 | −211.7 | 2.78 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 240 / 16608 (1.4%) | 11063 / 166080 (6.7%) | −213.8 | −211.4 | 0.22 |
| FOXA1 SRX1787653 | MCF-7 Breast | 198 / 16608 (1.2%) | 10233 / 166080 (6.2%) | −213.3 | −210.9 | 0.19 |
| MECOM SRX23677885 | HNT-34 Blood | 1864 / 16608 (11.2%) | 7972 / 166080 (4.8%) | −213.3 | −210.9 | 2.34 |
| SMARCA4 SRX5212357 | Mel270 Others | 414 / 16608 (2.5%) | 14141 / 166080 (8.5%) | −213.1 | −210.8 | 0.29 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 221 / 16608 (1.3%) | 10670 / 166080 (6.4%) | −212.9 | −210.5 | 0.21 |
| SMARCA4 SRX5212362 | Mel270 Others | 516 / 16608 (3.1%) | 15803 / 166080 (9.5%) | −212.8 | −210.4 | 0.33 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 512 / 16608 (3.1%) | 15735 / 166080 (9.5%) | −212.7 | −210.3 | 0.33 |
| TCF12 SRX190356 | SK-N-SH Neural | 854 / 16608 (5.1%) | 20925 / 166080 (12.6%) | −212.4 | −210.0 | 0.41 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 401 / 16608 (2.4%) | 13884 / 166080 (8.4%) | −212.0 | −209.7 | 0.29 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1893 / 16608 (11.4%) | 8200 / 166080 (4.9%) | −211.5 | −209.1 | 2.31 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 247 / 16608 (1.5%) | 11126 / 166080 (6.7%) | −211.5 | −209.1 | 0.22 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1888 / 16608 (11.4%) | 8210 / 166080 (4.9%) | −209.3 | −207.0 | 2.30 |
| ESR1 SRX20282939 | MCF-7 Breast | 329 / 16608 (2.0%) | 12558 / 166080 (7.6%) | −209.3 | −207.0 | 0.26 |
| JUN SRX4192884 | MCF 10A Breast | 209 / 16608 (1.3%) | 10329 / 166080 (6.2%) | −209.1 | −206.7 | 0.20 |
| MECOM SRX23677896 | HNT-34 Blood | 2221 / 16608 (13.4%) | 10492 / 166080 (6.3%) | −209.0 | −206.6 | 2.12 |
| MECOM SRX23677884 | HNT-34 Blood | 1826 / 16608 (11.0%) | 7808 / 166080 (4.7%) | −208.8 | −206.5 | 2.34 |
| ESR1 SRX20282960 | MCF-7 Breast | 332 / 16608 (2.0%) | 12582 / 166080 (7.6%) | −208.4 | −206.1 | 0.26 |
| MECOM SRX23677897 | HNT-34 Blood | 2144 / 16608 (12.9%) | 9970 / 166080 (6.0%) | −208.4 | −206.0 | 2.15 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 433 / 16608 (2.6%) | 14293 / 166080 (8.6%) | −208.0 | −205.7 | 0.30 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 522 / 16608 (3.1%) | 15730 / 166080 (9.5%) | −207.6 | −205.3 | 0.33 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 425 / 16608 (2.6%) | 14141 / 166080 (8.5%) | −207.4 | −205.1 | 0.30 |
| IRF3 SRX11453861 | Hep G2 Liver | 279 / 16608 (1.7%) | 90 / 166080 (0.1%) | −207.4 | −205.1 | 31.00 |
| ESR1 SRX176860 | MCF-7 Breast | 504 / 16608 (3.0%) | 15431 / 166080 (9.3%) | −207.3 | −205.0 | 0.33 |
| TP53 SRX19538282 | Osteoblasts Bone | 380 / 16608 (2.3%) | 304 / 166080 (0.2%) | −207.2 | −204.9 | 12.50 |
| ESR1 SRX371476 | MCF-7 Breast | 192 / 16608 (1.2%) | 9932 / 166080 (6.0%) | −207.0 | −204.7 | 0.19 |
| JUNB SRX10119386 | MCF 10A Breast | 235 / 16608 (1.4%) | 10763 / 166080 (6.5%) | −206.7 | −204.4 | 0.22 |
| GATA3 SRX5057632 | MCF-7 Breast | 157 / 16608 (0.9%) | 9212 / 166080 (5.5%) | −206.7 | −204.4 | 0.17 |
| SMARCA4 SRX5212371 | Mel270 Others | 415 / 16608 (2.5%) | 13951 / 166080 (8.4%) | −206.6 | −204.3 | 0.30 |
| FOXA1 SRX371480 | MCF-7 Breast | 168 / 16608 (1.0%) | 9426 / 166080 (5.7%) | −206.3 | −204.0 | 0.18 |
| ESR1 SRX194572 | MCF-7 Breast | 155 / 16608 (0.9%) | 9145 / 166080 (5.5%) | −205.8 | −203.5 | 0.17 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1811 / 16608 (10.9%) | 7798 / 166080 (4.7%) | −204.2 | −201.9 | 2.32 |
| FOXA1 SRX100454 | T-47D Breast | 382 / 16608 (2.3%) | 13310 / 166080 (8.0%) | −204.1 | −201.8 | 0.29 |
| ESR1 SRX371468 | MCF-7 Breast | 160 / 16608 (1.0%) | 9196 / 166080 (5.5%) | −204.0 | −201.7 | 0.17 |
| ESR1 SRX194569 | MCF-7 Breast | 301 / 16608 (1.8%) | 11882 / 166080 (7.2%) | −203.5 | −201.2 | 0.25 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 199 / 16608 (1.2%) | 9971 / 166080 (6.0%) | −203.5 | −201.2 | 0.20 |
| JUNB SRX4192882 | MCF 10A Breast | 203 / 16608 (1.2%) | 10029 / 166080 (6.0%) | −202.7 | −200.4 | 0.20 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 607 / 16608 (3.7%) | 16883 / 166080 (10.2%) | −202.4 | −200.1 | 0.36 |
| JUN SRX883584 | MDA-MB-231 Breast | 475 / 16608 (2.9%) | 14797 / 166080 (8.9%) | −202.3 | −200.0 | 0.32 |
| ESR1 SRX371467 | MCF-7 Breast | 306 / 16608 (1.8%) | 11914 / 166080 (7.2%) | −201.6 | −199.3 | 0.26 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 770 / 16608 (4.6%) | 19290 / 166080 (11.6%) | −201.1 | −198.8 | 0.40 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 251 / 16608 (1.5%) | 10870 / 166080 (6.5%) | −200.3 | −198.0 | 0.23 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 506 / 16608 (3.0%) | 15222 / 166080 (9.2%) | −200.0 | −197.8 | 0.33 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 179 / 16608 (1.1%) | 9477 / 166080 (5.7%) | −200.0 | −197.8 | 0.19 |
| BRPF3 SRX796084 | RKO Digestive tract | 1531 / 16608 (9.2%) | 6064 / 166080 (3.7%) | −200.0 | −197.8 | 2.52 |
| PRRX1 SRX15235713 | Hs 578T Breast | 358 / 16608 (2.2%) | 12773 / 166080 (7.7%) | −200.0 | −197.7 | 0.28 |
| JUNB SRX8488089 | SUM 229PE Breast | 284 / 16608 (1.7%) | 11434 / 166080 (6.9%) | −198.9 | −196.7 | 0.25 |
| BRPF3 SRX796085 | RKO Digestive tract | 1111 / 16608 (6.7%) | 3579 / 166080 (2.2%) | −198.7 | −196.5 | 3.10 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 387 / 16608 (2.3%) | 13214 / 166080 (8.0%) | −198.3 | −196.1 | 0.29 |
| FOXA1 SRX1161174 | MCF-7 Breast | 300 / 16608 (1.8%) | 11703 / 166080 (7.0%) | −198.3 | −196.0 | 0.26 |
| ARID1A SRX5089376 | MCF-7 Breast | 235 / 16608 (1.4%) | 10504 / 166080 (6.3%) | −198.0 | −195.7 | 0.22 |
| ESR1 SRX176861 | MCF-7 Breast | 522 / 16608 (3.1%) | 15388 / 166080 (9.3%) | −197.5 | −195.2 | 0.34 |
| JUNB SRX8488074 | SUM 229PE Breast | 403 / 16608 (2.4%) | 13419 / 166080 (8.1%) | −196.4 | −194.2 | 0.30 |
| CEBPB SRX150632 | HeLa Uterus | 733 / 16608 (4.4%) | 18570 / 166080 (11.2%) | −196.4 | −194.1 | 0.39 |
| VGLL1 SRX24602130 | BT-20 Breast | 304 / 16608 (1.8%) | 11702 / 166080 (7.0%) | −196.0 | −193.7 | 0.26 |
| ESR1 SRX1531791 | MCF-7 Breast | 284 / 16608 (1.7%) | 11336 / 166080 (6.8%) | −195.6 | −193.3 | 0.25 |
| FOXA1 SRX3923514 | MCF-7 Breast | 295 / 16608 (1.8%) | 11511 / 166080 (6.9%) | −194.9 | −192.7 | 0.26 |
| AR SRX1067066 | LHSAR Prostate | 671 / 16608 (4.0%) | 17594 / 166080 (10.6%) | −194.9 | −192.7 | 0.38 |
| NKX2-1 SRX2164786 | A549 Lung | 512 / 16608 (3.1%) | 15141 / 166080 (9.1%) | −194.8 | −192.6 | 0.34 |
| FOXA1 SRX3931043 | MCF-7 Breast | 297 / 16608 (1.8%) | 11520 / 166080 (6.9%) | −194.1 | −191.9 | 0.26 |
| BRPF3 SRX796086 | RKO Digestive tract | 1464 / 16608 (8.8%) | 5745 / 166080 (3.5%) | −194.0 | −191.8 | 2.55 |
| JUND SRX190357 | SK-N-SH Neural | 386 / 16608 (2.3%) | 13056 / 166080 (7.9%) | −194.0 | −191.7 | 0.30 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 294 / 16608 (1.8%) | 11457 / 166080 (6.9%) | −193.8 | −191.6 | 0.26 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 218 / 16608 (1.3%) | 10056 / 166080 (6.1%) | −193.7 | −191.5 | 0.22 |
| RAC1 SRX10365541 | MCF-7 Breast | 131 / 16608 (0.8%) | 8290 / 166080 (5.0%) | −193.3 | −191.1 | 0.16 |
| AR SRX1067067 | LHSAR Prostate | 534 / 16608 (3.2%) | 15423 / 166080 (9.3%) | −193.0 | −190.8 | 0.35 |
| FOSL2 SRX190296 | SK-N-SH Neural | 416 / 16608 (2.5%) | 13493 / 166080 (8.1%) | −192.0 | −189.8 | 0.31 |
| ESR1 SRX20282954 | MCF-7 Breast | 336 / 16608 (2.0%) | 12123 / 166080 (7.3%) | −191.4 | −189.1 | 0.28 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1938 / 16608 (11.7%) | 8918 / 166080 (5.4%) | −191.2 | −188.9 | 2.17 |
| FOXL2 SRX6957431 | KGN Gonad | 747 / 16608 (4.5%) | 18586 / 166080 (11.2%) | −191.1 | −188.9 | 0.40 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 392 / 16608 (2.4%) | 13057 / 166080 (7.9%) | −190.9 | −188.7 | 0.30 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 205 / 16608 (1.2%) | 9717 / 166080 (5.9%) | −190.6 | −188.4 | 0.21 |
| FOXA2 SRX3230382 | Hep G2 Liver | 423 / 16608 (2.5%) | 13550 / 166080 (8.2%) | −190.3 | −188.1 | 0.31 |
| TP53 SRX19538271 | U2OS Bone | 619 / 16608 (3.7%) | 1217 / 166080 (0.7%) | −190.0 | −187.8 | 5.09 |
| ESR1 SRX10365536 | MCF-7 Breast | 134 / 16608 (0.8%) | 8254 / 166080 (5.0%) | −189.7 | −187.5 | 0.16 |
| FOXA1 SRX11222441 | MCF-7 Breast | 217 / 16608 (1.3%) | 9907 / 166080 (6.0%) | −189.3 | −187.1 | 0.22 |
| MethylCap SRX014767 | NB-4 Blood | 1782 / 16608 (10.7%) | 7901 / 166080 (4.8%) | −189.1 | −186.9 | 2.26 |
| BRD4 SRX736204 | 90-8TL Neural | 951 / 16608 (5.7%) | 2824 / 166080 (1.7%) | −189.0 | −186.9 | 3.37 |
| SS18 SRX3468047 | Fibroblasts Others | 843 / 16608 (5.1%) | 19897 / 166080 (12.0%) | −189.0 | −186.8 | 0.42 |
| STAT3 SRX150630 | MCF 10A Breast | 266 / 16608 (1.6%) | 10806 / 166080 (6.5%) | −189.0 | −186.8 | 0.25 |
| DAXX SRX1021630 | PC-3 Prostate | 297 / 16608 (1.8%) | 11358 / 166080 (6.8%) | −188.8 | −186.7 | 0.26 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 221 / 16608 (1.3%) | 9968 / 166080 (6.0%) | −188.8 | −186.6 | 0.22 |
| FOXA1 SRX1787652 | MCF-7 Breast | 155 / 16608 (0.9%) | 8661 / 166080 (5.2%) | −188.6 | −186.4 | 0.18 |
| TLE3 SRX4815192 | MCF-7 Breast | 263 / 16608 (1.6%) | 10737 / 166080 (6.5%) | −188.4 | −186.2 | 0.24 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2089 / 16608 (12.6%) | 10032 / 166080 (6.0%) | −188.4 | −186.2 | 2.08 |
| STAT3 SRX150479 | MCF 10A Breast | 269 / 16608 (1.6%) | 10841 / 166080 (6.5%) | −188.3 | −186.2 | 0.25 |
| RORC SRX5359053 | HCC70 Breast | 1312 / 16608 (7.9%) | 4904 / 166080 (3.0%) | −188.1 | −185.9 | 2.68 |
| TET2 SRX2014505 | Jurkat Blood | 2655 / 16608 (16.0%) | 14164 / 166080 (8.5%) | −187.9 | −185.8 | 1.87 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 655 / 16608 (3.9%) | 1390 / 166080 (0.8%) | −187.6 | −185.4 | 4.71 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 444 / 16608 (2.7%) | 13806 / 166080 (8.3%) | −187.5 | −185.4 | 0.32 |
| AR SRX9469988 | LAPC-4 Prostate | 422 / 16608 (2.5%) | 13433 / 166080 (8.1%) | −187.1 | −185.0 | 0.31 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 331 / 16608 (2.0%) | 11903 / 166080 (7.2%) | −187.1 | −185.0 | 0.28 |
| ESR1 SRX371477 | MCF-7 Breast | 125 / 16608 (0.8%) | 7974 / 166080 (4.8%) | −186.7 | −184.5 | 0.16 |
| FOS SRX070879 | HUVEC Cardiovascular | 321 / 16608 (1.9%) | 11704 / 166080 (7.0%) | −186.4 | −184.2 | 0.27 |
| FOXA1 SRX11222442 | MCF-7 Breast | 183 / 16608 (1.1%) | 9154 / 166080 (5.5%) | −186.1 | −184.0 | 0.20 |
| EP300 SRX150579 | HeLa Uterus | 179 / 16608 (1.1%) | 9070 / 166080 (5.5%) | −186.0 | −183.8 | 0.20 |
| ESR1 SRX2943591 | MCF-7 Breast | 194 / 16608 (1.2%) | 9365 / 166080 (5.6%) | −185.9 | −183.8 | 0.21 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 118 / 16608 (0.7%) | 7795 / 166080 (4.7%) | −185.6 | −183.4 | 0.15 |
| PBX3 SRX190343 | SK-N-SH Neural | 694 / 16608 (4.2%) | 17593 / 166080 (10.6%) | −185.4 | −183.2 | 0.39 |
| FOXA1 SRX100506 | Hep G2 Liver | 420 / 16608 (2.5%) | 13327 / 166080 (8.0%) | −184.9 | −182.7 | 0.32 |
| FOXA1 SRX11222437 | MCF-7 Breast | 205 / 16608 (1.2%) | 9545 / 166080 (5.7%) | −184.8 | −182.7 | 0.21 |
| JUNB SRX10119383 | MCF 10A Breast | 190 / 16608 (1.1%) | 9248 / 166080 (5.6%) | −184.6 | −182.5 | 0.21 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 428 / 16608 (2.6%) | 13442 / 166080 (8.1%) | −184.5 | −182.3 | 0.32 |
| ESR1 SRX20282972 | MCF-7 Breast | 357 / 16608 (2.1%) | 12261 / 166080 (7.4%) | −184.5 | −182.3 | 0.29 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 310 / 16608 (1.9%) | 11448 / 166080 (6.9%) | −184.3 | −182.2 | 0.27 |
| JUN SRX2355072 | HAEC Cardiovascular | 412 / 16608 (2.5%) | 13173 / 166080 (7.9%) | −184.3 | −182.2 | 0.31 |
| FOXA1 SRX3931055 | MCF-7 Breast | 249 / 16608 (1.5%) | 10351 / 166080 (6.2%) | −184.2 | −182.1 | 0.24 |
| FOXA1 SRX3931054 | MCF-7 Breast | 282 / 16608 (1.7%) | 10948 / 166080 (6.6%) | −184.1 | −182.0 | 0.26 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 175 / 16608 (1.1%) | 8933 / 166080 (5.4%) | −183.9 | −181.7 | 0.20 |
| GATA3 SRX6712581 | MCF-7 Breast | 241 / 16608 (1.5%) | 10179 / 166080 (6.1%) | −183.4 | −181.3 | 0.24 |
| RORC SRX5359052 | HCC70 Breast | 1331 / 16608 (8.0%) | 5102 / 166080 (3.1%) | −183.0 | −180.8 | 2.61 |
| YAP1 SRX10119364 | MCF 10A Breast | 249 / 16608 (1.5%) | 10313 / 166080 (6.2%) | −182.8 | −180.7 | 0.24 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 506 / 16608 (3.0%) | 14623 / 166080 (8.8%) | −182.4 | −180.3 | 0.35 |
| RAC1 SRX10365543 | MCF-7 Breast | 146 / 16608 (0.9%) | 8292 / 166080 (5.0%) | −182.0 | −179.9 | 0.18 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1274 / 16608 (7.7%) | 4776 / 166080 (2.9%) | −181.6 | −179.5 | 2.67 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 408 / 16608 (2.5%) | 13008 / 166080 (7.8%) | −181.3 | −179.1 | 0.31 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 767 / 16608 (4.6%) | 18498 / 166080 (11.1%) | −180.8 | −178.7 | 0.41 |
| ESR1 SRX371475 | BT-474 Breast | 133 / 16608 (0.8%) | 7983 / 166080 (4.8%) | −180.7 | −178.5 | 0.17 |
| FOXA1 SRX028634 | MCF-7 Breast | 125 / 16608 (0.8%) | 7808 / 166080 (4.7%) | −180.7 | −178.5 | 0.16 |
| MEAF6 DRX234811 | 293 Kidney | 1679 / 16608 (10.1%) | 7381 / 166080 (4.4%) | −180.6 | −178.5 | 2.27 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 994 / 16608 (6.0%) | 21694 / 166080 (13.1%) | −180.4 | −178.3 | 0.46 |
| STAT3 SRX150536 | MCF 10A Breast | 349 / 16608 (2.1%) | 11992 / 166080 (7.2%) | −180.4 | −178.3 | 0.29 |
| FOXA1 SRX1787655 | MCF-7 Breast | 126 / 16608 (0.8%) | 7819 / 166080 (4.7%) | −180.2 | −178.0 | 0.16 |
| FOS SRX3322636 | MCF-7 Breast | 177 / 16608 (1.1%) | 8861 / 166080 (5.3%) | −180.0 | −177.9 | 0.20 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 289 / 16608 (1.7%) | 10944 / 166080 (6.6%) | −180.0 | −177.9 | 0.26 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 214 / 16608 (1.3%) | 9556 / 166080 (5.8%) | −179.4 | −177.3 | 0.22 |
| JUND SRX150408 | HeLa Uterus | 268 / 16608 (1.6%) | 10542 / 166080 (6.3%) | −179.0 | −176.9 | 0.25 |
| EP300 SRX2194265 | SUM 159PT Breast | 524 / 16608 (3.2%) | 14783 / 166080 (8.9%) | −178.9 | −176.8 | 0.35 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 288 / 16608 (1.7%) | 10892 / 166080 (6.6%) | −178.9 | −176.8 | 0.26 |
| FOXA2 SRX100448 | Hep G2 Liver | 350 / 16608 (2.1%) | 11950 / 166080 (7.2%) | −178.4 | −176.3 | 0.29 |
| ARID1A SRX5089379 | MCF-7 Breast | 307 / 16608 (1.8%) | 11212 / 166080 (6.8%) | −178.4 | −176.3 | 0.27 |
| FOXA1 SRX1787651 | MCF-7 Breast | 155 / 16608 (0.9%) | 8372 / 166080 (5.0%) | −178.4 | −176.3 | 0.19 |
| NR2F2 SRX190293 | MCF-7 Breast | 343 / 16608 (2.1%) | 11813 / 166080 (7.1%) | −177.9 | −175.9 | 0.29 |
| FOXA1 SRX028635 | MCF-7 Breast | 129 / 16608 (0.8%) | 7813 / 166080 (4.7%) | −177.8 | −175.7 | 0.17 |
| ERG SRX063922 | K-562 Blood | 1582 / 16608 (9.5%) | 6799 / 166080 (4.1%) | −177.5 | −175.4 | 2.33 |
| TEAD1 SRX3401272 | MCF-7 Breast | 229 / 16608 (1.4%) | 9773 / 166080 (5.9%) | −177.3 | −175.2 | 0.23 |
| FOXA1 SRX3923517 | MCF-7 Breast | 208 / 16608 (1.3%) | 9368 / 166080 (5.6%) | −176.8 | −174.7 | 0.22 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 587 / 16608 (3.5%) | 15675 / 166080 (9.4%) | −176.7 | −174.7 | 0.37 |
| AR SRX10820653 | LNCAP Prostate | 312 / 16608 (1.9%) | 229 / 166080 (0.1%) | −176.7 | −174.7 | 13.62 |
| FOXA1 SRX1161203 | T-47D Breast | 212 / 16608 (1.3%) | 9439 / 166080 (5.7%) | −176.6 | −174.5 | 0.22 |
| TP53 SRX396254 | Fibroblasts Others | 893 / 16608 (5.4%) | 2663 / 166080 (1.6%) | −176.3 | −174.2 | 3.35 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 703 / 16608 (4.2%) | 1708 / 166080 (1.0%) | −175.9 | −173.8 | 4.12 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 623 / 16608 (3.8%) | 16182 / 166080 (9.7%) | −175.7 | −173.6 | 0.38 |
| RELA SRX5938177 | FaDu Others | 286 / 16608 (1.7%) | 10751 / 166080 (6.5%) | −175.6 | −173.5 | 0.27 |
| FOXA1 SRX3931033 | MCF-7 Breast | 185 / 16608 (1.1%) | 8876 / 166080 (5.3%) | −175.1 | −173.1 | 0.21 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 640 / 16608 (3.9%) | 1430 / 166080 (0.9%) | −174.3 | −172.2 | 4.48 |
| ESR1 SRX20282946 | MCF-7 Breast | 173 / 16608 (1.0%) | 8608 / 166080 (5.2%) | −174.1 | −172.0 | 0.20 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1082 / 16608 (6.5%) | 3746 / 166080 (2.3%) | −173.9 | −171.8 | 2.89 |
| MEAF6 DRX300417 | 293 Kidney | 1531 / 16608 (9.2%) | 6538 / 166080 (3.9%) | −173.8 | −171.7 | 2.34 |
| ARID5B SRX3230377 | Hep G2 Liver | 865 / 16608 (5.2%) | 19627 / 166080 (11.8%) | −173.8 | −171.7 | 0.44 |
| FOXA1 SRX3923518 | MCF-7 Breast | 205 / 16608 (1.2%) | 9218 / 166080 (5.6%) | −173.7 | −171.6 | 0.22 |
| ESR1 SRX20282973 | MCF-7 Breast | 403 / 16608 (2.4%) | 12667 / 166080 (7.6%) | −173.4 | −171.3 | 0.32 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 302 / 16608 (1.8%) | 10960 / 166080 (6.6%) | −173.2 | −171.1 | 0.28 |
| FOXA1 SRX3923516 | MCF-7 Breast | 218 / 16608 (1.3%) | 9443 / 166080 (5.7%) | −173.1 | −171.0 | 0.23 |
| JUN SRX6582171 | GM07492 Others | 676 / 16608 (4.1%) | 16858 / 166080 (10.2%) | −172.5 | −170.5 | 0.40 |
| FOXA1 SRX5323843 | MCF-7 Breast | 143 / 16608 (0.9%) | 7955 / 166080 (4.8%) | −172.4 | −170.3 | 0.18 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 451 / 16608 (2.7%) | 13404 / 166080 (8.1%) | −172.4 | −170.3 | 0.34 |
| FOSL2 SRX190204 | A549 Lung | 318 / 16608 (1.9%) | 11206 / 166080 (6.7%) | −172.3 | −170.2 | 0.28 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 455 / 16608 (2.7%) | 13464 / 166080 (8.1%) | −172.2 | −170.1 | 0.34 |
| FOS SRX150664 | HUVEC Cardiovascular | 444 / 16608 (2.7%) | 13282 / 166080 (8.0%) | −172.0 | −169.9 | 0.33 |
| FOXA1 SRX11222438 | MCF-7 Breast | 153 / 16608 (0.9%) | 8140 / 166080 (4.9%) | −171.7 | −169.6 | 0.19 |
| PGR SRX1012655 | MCF-7 Breast | 188 / 16608 (1.1%) | 8827 / 166080 (5.3%) | −171.4 | −169.4 | 0.21 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 293 / 16608 (1.8%) | 10745 / 166080 (6.5%) | −171.4 | −169.3 | 0.27 |
| FOXA1 SRX1447317 | MCF-7 Breast | 195 / 16608 (1.2%) | 8955 / 166080 (5.4%) | −171.2 | −169.2 | 0.22 |
| ESR1 SRX10365532 | MCF-7 Breast | 159 / 16608 (1.0%) | 8244 / 166080 (5.0%) | −171.1 | −169.1 | 0.19 |
| ZFX SRX7805372 | 293 Kidney | 1553 / 16608 (9.4%) | 6736 / 166080 (4.1%) | −171.0 | −169.0 | 2.31 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 522 / 16608 (3.1%) | 950 / 166080 (0.6%) | −171.0 | −169.0 | 5.49 |
| WWTR1 SRX10119367 | MCF 10A Breast | 392 / 16608 (2.4%) | 12378 / 166080 (7.5%) | −170.2 | −168.2 | 0.32 |
| NR3C1 SRX17639412 | A549 Lung | 367 / 16608 (2.2%) | 11960 / 166080 (7.2%) | −170.0 | −167.9 | 0.31 |
| JUN SRX2355073 | HAEC Cardiovascular | 422 / 16608 (2.5%) | 12856 / 166080 (7.7%) | −169.9 | −167.9 | 0.33 |
| ESR1 SRX20282940 | MCF-7 Breast | 365 / 16608 (2.2%) | 11922 / 166080 (7.2%) | −169.9 | −167.8 | 0.31 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 138 / 16608 (0.8%) | 7783 / 166080 (4.7%) | −169.9 | −167.8 | 0.18 |
| Epitope tags SRX2255894 | 293 Kidney | 1370 / 16608 (8.2%) | 5572 / 166080 (3.4%) | −169.8 | −167.7 | 2.46 |
| ESR1 SRX371474 | BT-474 Breast | 132 / 16608 (0.8%) | 7651 / 166080 (4.6%) | −169.6 | −167.6 | 0.17 |
| EP300 SRX2671813 | Fibroblasts Others | 273 / 16608 (1.6%) | 10332 / 166080 (6.2%) | −169.4 | −167.4 | 0.26 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 888 / 16608 (5.3%) | 19781 / 166080 (11.9%) | −169.4 | −167.4 | 0.45 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 261 / 16608 (1.6%) | 10113 / 166080 (6.1%) | −169.3 | −167.3 | 0.26 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 218 / 16608 (1.3%) | 9328 / 166080 (5.6%) | −169.3 | −167.3 | 0.23 |
| FOXA1 SRX3923519 | MCF-7 Breast | 182 / 16608 (1.1%) | 8644 / 166080 (5.2%) | −169.2 | −167.2 | 0.21 |
| ESR1 SRX4367192 | MCF-7 Breast | 708 / 16608 (4.3%) | 17197 / 166080 (10.4%) | −169.1 | −167.0 | 0.41 |
| JUNB SRX10119384 | MCF 10A Breast | 180 / 16608 (1.1%) | 8597 / 166080 (5.2%) | −169.0 | −166.9 | 0.21 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 598 / 16608 (3.6%) | 15562 / 166080 (9.4%) | −168.9 | −166.9 | 0.38 |
| STAT3 SRX2020842 | HCC70 Breast | 613 / 16608 (3.7%) | 15787 / 166080 (9.5%) | −168.9 | −166.9 | 0.39 |
| FOXA1 SRX15430999 | T-47D Breast | 372 / 16608 (2.2%) | 12003 / 166080 (7.2%) | −168.9 | −166.9 | 0.31 |
| ESR1 SRX1012632 | MCF-7 Breast | 139 / 16608 (0.8%) | 7767 / 166080 (4.7%) | −168.6 | −166.6 | 0.18 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 614 / 16608 (3.7%) | 15776 / 166080 (9.5%) | −168.3 | −166.3 | 0.39 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 277 / 16608 (1.7%) | 10361 / 166080 (6.2%) | −168.2 | −166.2 | 0.27 |
| GATAD2A SRX2636506 | Hep G2 Liver | 436 / 16608 (2.6%) | 13013 / 166080 (7.8%) | −167.9 | −165.9 | 0.34 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 535 / 16608 (3.2%) | 14560 / 166080 (8.8%) | −167.7 | −165.7 | 0.37 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 345 / 16608 (2.1%) | 11517 / 166080 (6.9%) | −167.6 | −165.6 | 0.30 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 358 / 16608 (2.2%) | 11716 / 166080 (7.1%) | −167.2 | −165.2 | 0.31 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 129 / 16608 (0.8%) | 7520 / 166080 (4.5%) | −167.1 | −165.1 | 0.17 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 209 / 16608 (1.3%) | 9095 / 166080 (5.5%) | −167.1 | −165.1 | 0.23 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 281 / 16608 (1.7%) | 10395 / 166080 (6.3%) | −166.9 | −164.9 | 0.27 |
| FOXA1 SRX190181 | A549 Lung | 225 / 16608 (1.4%) | 9385 / 166080 (5.7%) | −166.8 | −164.8 | 0.24 |
| FOXA1 SRX3931056 | MCF-7 Breast | 177 / 16608 (1.1%) | 8470 / 166080 (5.1%) | −166.6 | −164.6 | 0.21 |
| ESR1 SRX330067 | MCF-7 Breast | 299 / 16608 (1.8%) | 10692 / 166080 (6.4%) | −166.5 | −164.5 | 0.28 |
| MethylCap SRX014766 | NB-4 Blood | 1565 / 16608 (9.4%) | 6908 / 166080 (4.2%) | −166.4 | −164.4 | 2.27 |
| ESR1 SRX2943589 | MCF-7 Breast | 147 / 16608 (0.9%) | 7867 / 166080 (4.7%) | −166.3 | −164.3 | 0.19 |
| ESR1 SRX330070 | MCF-7 Breast | 151 / 16608 (0.9%) | 7933 / 166080 (4.8%) | −165.8 | −163.8 | 0.19 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 530 / 16608 (3.2%) | 14408 / 166080 (8.7%) | −165.5 | −163.6 | 0.37 |
| ERG SRX063921 | K-562 Blood | 1481 / 16608 (8.9%) | 6369 / 166080 (3.8%) | −165.5 | −163.5 | 2.33 |
| Epitope tags DRX443510 | 293 Kidney | 1432 / 16608 (8.6%) | 6049 / 166080 (3.6%) | −165.5 | −163.5 | 2.37 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 254 / 16608 (1.5%) | 130 / 166080 (0.1%) | −165.2 | −163.2 | 19.54 |
| ING5 SRX286202 | RKO Digestive tract | 1284 / 16608 (7.7%) | 5109 / 166080 (3.1%) | −165.1 | −163.1 | 2.51 |
| FOXA1 SRX5203303 | MCF-7 Breast | 85 / 16608 (0.5%) | 6492 / 166080 (3.9%) | −164.9 | −162.9 | 0.13 |
| JUN SRX6582172 | Fibroblasts Others | 462 / 16608 (2.8%) | 13309 / 166080 (8.0%) | −164.5 | −162.5 | 0.35 |
| GATA3 SRX5457550 | MCF-7 Breast | 387 / 16608 (2.3%) | 12095 / 166080 (7.3%) | −164.1 | −162.1 | 0.32 |
| ESR1 SRX10365535 | MCF-7 Breast | 275 / 16608 (1.7%) | 10195 / 166080 (6.1%) | −164.0 | −162.0 | 0.27 |
| TET2 SRX1427029 | 293 Kidney | 1290 / 16608 (7.8%) | 5165 / 166080 (3.1%) | −163.9 | −161.9 | 2.50 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 320 / 16608 (1.9%) | 10961 / 166080 (6.6%) | −163.7 | −161.7 | 0.29 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 466 / 16608 (2.8%) | 13338 / 166080 (8.0%) | −163.5 | −161.5 | 0.35 |
| FOXA1 SRX3923515 | MCF-7 Breast | 170 / 16608 (1.0%) | 8243 / 166080 (5.0%) | −163.5 | −161.5 | 0.21 |
| SOX13 SRX2636248 | Hep G2 Liver | 482 / 16608 (2.9%) | 13576 / 166080 (8.2%) | −163.1 | −161.2 | 0.36 |
| ESR1 SRX3123829 | MCF-7 Breast | 178 / 16608 (1.1%) | 8389 / 166080 (5.1%) | −163.1 | −161.1 | 0.21 |
| FOXA1 SRX5323829 | T-47D Breast | 172 / 16608 (1.0%) | 8270 / 166080 (5.0%) | −163.1 | −161.1 | 0.21 |
| FOXA1 SRX100477 | Hep G2 Liver | 390 / 16608 (2.3%) | 12107 / 166080 (7.3%) | −163.1 | −161.1 | 0.32 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 285 / 16608 (1.7%) | 10337 / 166080 (6.2%) | −163.0 | −161.0 | 0.28 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 322 / 16608 (1.9%) | 10970 / 166080 (6.6%) | −162.9 | −160.9 | 0.29 |
| ESR1 SRX1012629 | MCF-7 Breast | 198 / 16608 (1.2%) | 8763 / 166080 (5.3%) | −162.8 | −160.8 | 0.23 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 273 / 16608 (1.6%) | 10120 / 166080 (6.1%) | −162.8 | −160.8 | 0.27 |
| ARID5B SRX10475139 | Hep G2 Liver | 375 / 16608 (2.3%) | 11841 / 166080 (7.1%) | −162.5 | −160.5 | 0.32 |
| EP300 SRX1012648 | MCF-7 Breast | 139 / 16608 (0.8%) | 7592 / 166080 (4.6%) | −162.4 | −160.5 | 0.18 |
| ESR1 SRX20282955 | MCF-7 Breast | 369 / 16608 (2.2%) | 11743 / 166080 (7.1%) | −162.4 | −160.5 | 0.31 |
| ESR1 SRX330069 | MCF-7 Breast | 195 / 16608 (1.2%) | 8683 / 166080 (5.2%) | −162.2 | −160.2 | 0.22 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 414 / 16608 (2.5%) | 12461 / 166080 (7.5%) | −162.1 | −160.1 | 0.33 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 288 / 16608 (1.7%) | 10357 / 166080 (6.2%) | −162.0 | −160.0 | 0.28 |
| ESR1 SRX20282971 | MCF-7 Breast | 340 / 16608 (2.0%) | 11246 / 166080 (6.8%) | −161.9 | −160.0 | 0.30 |
| SMARCA4 SRX5982340 | A549 Lung | 113 / 16608 (0.7%) | 7029 / 166080 (4.2%) | −161.8 | −159.8 | 0.16 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 527 / 16608 (3.2%) | 14219 / 166080 (8.6%) | −161.7 | −159.7 | 0.37 |
| CEBPA SRX2630241 | Hep G2 Liver | 424 / 16608 (2.6%) | 12596 / 166080 (7.6%) | −161.3 | −159.4 | 0.34 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 217 / 16608 (1.3%) | 9061 / 166080 (5.5%) | −161.0 | −159.1 | 0.24 |
| ZEB1 SRX13298925 | MCF-7 Breast | 194 / 16608 (1.2%) | 8632 / 166080 (5.2%) | −161.0 | −159.1 | 0.22 |
| JUND SRX699738 | HCASMC Cardiovascular | 494 / 16608 (3.0%) | 13690 / 166080 (8.2%) | −161.0 | −159.1 | 0.36 |
| FOXA1 SRX1787654 | MCF-7 Breast | 100 / 16608 (0.6%) | 6721 / 166080 (4.0%) | −160.9 | −159.0 | 0.15 |
| ESR1 SRX4451213 | MCF-7 Breast | 348 / 16608 (2.1%) | 11342 / 166080 (6.8%) | −160.9 | −158.9 | 0.31 |
| SP1 SRX190358 | HCT 116 Digestive tract | 550 / 16608 (3.3%) | 14538 / 166080 (8.8%) | −160.7 | −158.8 | 0.38 |
| EP300 SRX1012644 | MCF-7 Breast | 131 / 16608 (0.8%) | 7379 / 166080 (4.4%) | −160.6 | −158.7 | 0.18 |
| FOXA1 SRX1161205 | T-47D Breast | 164 / 16608 (1.0%) | 8041 / 166080 (4.8%) | −160.5 | −158.6 | 0.20 |
| ESR1 SRX10365533 | MCF-7 Breast | 144 / 16608 (0.9%) | 7635 / 166080 (4.6%) | −160.4 | −158.4 | 0.19 |
| RELA SRX7055007 | HAEC Cardiovascular | 650 / 16608 (3.9%) | 16017 / 166080 (9.6%) | −160.3 | −158.4 | 0.41 |
| ARID1A SRX5089391 | MCF-7 Breast | 174 / 16608 (1.0%) | 8226 / 166080 (5.0%) | −160.3 | −158.3 | 0.21 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 500 / 16608 (3.0%) | 13756 / 166080 (8.3%) | −160.2 | −158.3 | 0.36 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 953 / 16608 (5.7%) | 20312 / 166080 (12.2%) | −160.2 | −158.3 | 0.47 |
| EP300 SRX176885 | MCF-7 Breast | 160 / 16608 (1.0%) | 7952 / 166080 (4.8%) | −160.2 | −158.2 | 0.20 |
| FOXA1 SRX6878603 | LNCAP Prostate | 380 / 16608 (2.3%) | 11845 / 166080 (7.1%) | −160.1 | −158.2 | 0.32 |
| ESR1 SRX3110725 | MCF-7 Breast | 302 / 16608 (1.8%) | 10541 / 166080 (6.3%) | −160.1 | −158.2 | 0.29 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1084 / 16608 (6.5%) | 22075 / 166080 (13.3%) | −159.8 | −157.9 | 0.49 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 222 / 16608 (1.3%) | 9109 / 166080 (5.5%) | −159.6 | −157.7 | 0.24 |
| ESR1 SRX8537722 | MCF-7 Breast | 317 / 16608 (1.9%) | 10781 / 166080 (6.5%) | −159.6 | −157.7 | 0.29 |
| FOXA1 SRX219284 | LNCAP Prostate | 470 / 16608 (2.8%) | 13265 / 166080 (8.0%) | −159.6 | −157.7 | 0.35 |
| MECOM SRX23677890 | HNT-34 Blood | 1769 / 16608 (10.7%) | 8452 / 166080 (5.1%) | −159.4 | −157.5 | 2.09 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 101 / 16608 (0.6%) | 6687 / 166080 (4.0%) | −158.8 | −156.9 | 0.15 |
| ESR1 SRX20282953 | MCF-7 Breast | 280 / 16608 (1.7%) | 10118 / 166080 (6.1%) | −158.8 | −156.9 | 0.28 |
| RELA SRX7054617 | HAEC Cardiovascular | 424 / 16608 (2.6%) | 12509 / 166080 (7.5%) | −158.7 | −156.8 | 0.34 |
| EP300 SRX1012643 | MCF-7 Breast | 98 / 16608 (0.6%) | 6608 / 166080 (4.0%) | −158.4 | −156.5 | 0.15 |
| FOXA1 SRX1961158 | T-47D Breast | 343 / 16608 (2.1%) | 11172 / 166080 (6.7%) | −158.2 | −156.2 | 0.31 |
| JUN SRX150358 | HUVEC Cardiovascular | 207 / 16608 (1.2%) | 8791 / 166080 (5.3%) | −158.2 | −156.2 | 0.24 |
| KMT2A SRX2323891 | 293 Kidney | 972 / 16608 (5.9%) | 3334 / 166080 (2.0%) | −158.1 | −156.2 | 2.92 |
| PROX1 SRX3230397 | Hep G2 Liver | 246 / 16608 (1.5%) | 9495 / 166080 (5.7%) | −158.0 | −156.1 | 0.26 |
| FOXA1 SRX1961157 | T-47D Breast | 380 / 16608 (2.3%) | 11771 / 166080 (7.1%) | −157.9 | −156.0 | 0.32 |
| ESR1 SRX1531796 | MCF-7 Breast | 167 / 16608 (1.0%) | 8017 / 166080 (4.8%) | −157.7 | −155.8 | 0.21 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 217 / 16608 (1.3%) | 8960 / 166080 (5.4%) | −157.7 | −155.8 | 0.24 |
| ESR1 SRX2881000 | MCF-7 Breast | 302 / 16608 (1.8%) | 10462 / 166080 (6.3%) | −157.7 | −155.7 | 0.29 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 276 / 16608 (1.7%) | 10008 / 166080 (6.0%) | −157.5 | −155.6 | 0.28 |
| RELA SRX7054657 | HAEC Cardiovascular | 397 / 16608 (2.4%) | 12029 / 166080 (7.2%) | −157.4 | −155.5 | 0.33 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 327 / 16608 (2.0%) | 10876 / 166080 (6.5%) | −157.3 | −155.4 | 0.30 |
| FOXA1 SRX13814018 | 5637 Others | 205 / 16608 (1.2%) | 8718 / 166080 (5.2%) | −157.1 | −155.2 | 0.24 |
| JUN SRX6582163 | BJ-5ta Epidermis | 453 / 16608 (2.7%) | 12907 / 166080 (7.8%) | −157.0 | −155.1 | 0.35 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 299 / 16608 (1.8%) | 10388 / 166080 (6.3%) | −156.9 | −155.0 | 0.29 |
| ESR1 SRX2881002 | MCF-7 Breast | 332 / 16608 (2.0%) | 10946 / 166080 (6.6%) | −156.9 | −155.0 | 0.30 |
| STAT5B SRX831881 | CD8+ T cells Blood | 255 / 16608 (1.5%) | 153 / 166080 (0.1%) | −156.7 | −154.8 | 16.67 |
| FOXA1 SRX3931032 | MCF-7 Breast | 188 / 16608 (1.1%) | 8388 / 166080 (5.1%) | −156.7 | −154.8 | 0.22 |
| FOXA1 SRX5203294 | MCF-7 Breast | 74 / 16608 (0.4%) | 6007 / 166080 (3.6%) | −156.4 | −154.5 | 0.12 |
| ARID1A SRX5089382 | MCF-7 Breast | 234 / 16608 (1.4%) | 9223 / 166080 (5.6%) | −156.2 | −154.3 | 0.25 |
| ESR1 SRX2912055 | MCF-7 Breast | 113 / 16608 (0.7%) | 6874 / 166080 (4.1%) | −156.1 | −154.2 | 0.16 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 211 / 16608 (1.3%) | 8798 / 166080 (5.3%) | −156.1 | −154.2 | 0.24 |
| ARID1A SRX5089385 | MCF-7 Breast | 249 / 16608 (1.5%) | 9487 / 166080 (5.7%) | −156.1 | −154.2 | 0.26 |
| RELA SRX7054663 | HAEC Cardiovascular | 295 / 16608 (1.8%) | 10291 / 166080 (6.2%) | −156.0 | −154.1 | 0.29 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 428 / 16608 (2.6%) | 12473 / 166080 (7.5%) | −155.8 | −153.9 | 0.34 |
| FOXA1 SRX6860635 | T-47D Breast | 255 / 16608 (1.5%) | 9584 / 166080 (5.8%) | −155.7 | −153.8 | 0.27 |
| ESR1 SRX20282938 | MCF-7 Breast | 278 / 16608 (1.7%) | 9980 / 166080 (6.0%) | −155.6 | −153.7 | 0.28 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1089 / 16608 (6.6%) | 4065 / 166080 (2.4%) | −155.5 | −153.6 | 2.68 |
| NR3C1 SRX19024866 | MCF-7 Breast | 97 / 16608 (0.6%) | 6508 / 166080 (3.9%) | −155.5 | −153.6 | 0.15 |
| MECOM SRX23677891 | HNT-34 Blood | 1747 / 16608 (10.5%) | 8390 / 166080 (5.1%) | −155.5 | −153.6 | 2.08 |
| AR SRX1067068 | LHSAR Prostate | 425 / 16608 (2.6%) | 12409 / 166080 (7.5%) | −155.4 | −153.5 | 0.34 |
| EP300 SRX2194266 | SUM 159PT Breast | 634 / 16608 (3.8%) | 15597 / 166080 (9.4%) | −155.3 | −153.4 | 0.41 |
| EP300 SRX100540 | SK-N-SH Neural | 529 / 16608 (3.2%) | 14023 / 166080 (8.4%) | −155.3 | −153.4 | 0.38 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 523 / 16608 (3.1%) | 13927 / 166080 (8.4%) | −155.3 | −153.4 | 0.38 |
| ESR1 SRX20282959 | MCF-7 Breast | 127 / 16608 (0.8%) | 7141 / 166080 (4.3%) | −155.2 | −153.3 | 0.18 |
| FOXA1 SRX190282 | A549 Lung | 234 / 16608 (1.4%) | 9191 / 166080 (5.5%) | −155.1 | −153.2 | 0.25 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1621 / 16608 (9.8%) | 7541 / 166080 (4.5%) | −154.4 | −152.5 | 2.15 |
| ESR1 SRX1012633 | MCF-7 Breast | 163 / 16608 (1.0%) | 7835 / 166080 (4.7%) | −154.3 | −152.4 | 0.21 |
| HMG20A SRX2630163 | Hep G2 Liver | 188 / 16608 (1.1%) | 8317 / 166080 (5.0%) | −154.2 | −152.3 | 0.23 |
| FOXA1 SRX1161207 | T-47D Breast | 125 / 16608 (0.8%) | 7071 / 166080 (4.3%) | −154.2 | −152.3 | 0.18 |
| ESR1 SRX1012630 | MCF-7 Breast | 114 / 16608 (0.7%) | 6834 / 166080 (4.1%) | −154.1 | −152.2 | 0.17 |
| ESR1 SRX1469949 | MCF-7 Breast | 189 / 16608 (1.1%) | 8323 / 166080 (5.0%) | −153.9 | −152.0 | 0.23 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 465 / 16608 (2.8%) | 12982 / 166080 (7.8%) | −153.8 | −151.9 | 0.36 |
| Epitope tags SRX10549778 | K-562 Blood | 1085 / 16608 (6.5%) | 4074 / 166080 (2.5%) | −153.4 | −151.5 | 2.66 |
| FOXA1 SRX5203307 | MCF-7 Breast | 82 / 16608 (0.5%) | 6099 / 166080 (3.7%) | −153.0 | −151.2 | 0.13 |
| FOXL2 SRX6957477 | KGN Gonad | 375 / 16608 (2.3%) | 11522 / 166080 (6.9%) | −153.0 | −151.1 | 0.33 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 301 / 16608 (1.8%) | 10293 / 166080 (6.2%) | −153.0 | −151.1 | 0.29 |
| FOXA1 SRX9604647 | LNCAP Prostate | 547 / 16608 (3.3%) | 14205 / 166080 (8.6%) | −152.8 | −150.9 | 0.39 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 349 / 16608 (2.1%) | 11087 / 166080 (6.7%) | −152.7 | −150.8 | 0.31 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 214 / 16608 (1.3%) | 8742 / 166080 (5.3%) | −152.4 | −150.5 | 0.24 |
| LEO1 SRX1873456 | SEM Blood | 1395 / 16608 (8.4%) | 6059 / 166080 (3.6%) | −152.4 | −150.5 | 2.30 |
| FOXA1 SRX5323830 | T-47D Breast | 202 / 16608 (1.2%) | 8519 / 166080 (5.1%) | −152.4 | −150.5 | 0.24 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 225 / 16608 (1.4%) | 8939 / 166080 (5.4%) | −152.3 | −150.4 | 0.25 |
| EP300 SRX10976215 | A549 Lung | 326 / 16608 (2.0%) | 10688 / 166080 (6.4%) | −152.2 | −150.4 | 0.31 |
| FOXA1 SRX1447316 | MCF-7 Breast | 132 / 16608 (0.8%) | 7156 / 166080 (4.3%) | −152.2 | −150.3 | 0.18 |
| FOS SRX3322637 | MCF-7 Breast | 172 / 16608 (1.0%) | 7945 / 166080 (4.8%) | −152.0 | −150.2 | 0.22 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 421 / 16608 (2.5%) | 12217 / 166080 (7.4%) | −151.6 | −149.8 | 0.34 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 216 / 16608 (1.3%) | 8749 / 166080 (5.3%) | −151.4 | −149.5 | 0.25 |
| ESR1 SRX4451212 | MCF-7 Breast | 338 / 16608 (2.0%) | 10857 / 166080 (6.5%) | −151.3 | −149.4 | 0.31 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1315 / 16608 (7.9%) | 5563 / 166080 (3.3%) | −151.0 | −149.1 | 2.36 |
| VGLL1 SRX18013277 | FULVR Breast | 137 / 16608 (0.8%) | 7220 / 166080 (4.3%) | −150.9 | −149.0 | 0.19 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 95 / 16608 (0.6%) | 6326 / 166080 (3.8%) | −150.5 | −148.6 | 0.15 |
| GRHL3 SRX2582161 | NHEK Epidermis | 892 / 16608 (5.4%) | 2987 / 166080 (1.8%) | −150.1 | −148.2 | 2.99 |
| JUNB SRX10119385 | MCF 10A Breast | 147 / 16608 (0.9%) | 7395 / 166080 (4.5%) | −150.0 | −148.2 | 0.20 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 538 / 16608 (3.2%) | 13961 / 166080 (8.4%) | −150.0 | −148.1 | 0.39 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 197 / 16608 (1.2%) | 8350 / 166080 (5.0%) | −149.9 | −148.0 | 0.24 |
| FOXA1 SRX5323845 | MCF-7 Breast | 110 / 16608 (0.7%) | 6630 / 166080 (4.0%) | −149.8 | −147.9 | 0.17 |
| GATA3 SRX100559 | T-47D Breast | 398 / 16608 (2.4%) | 11776 / 166080 (7.1%) | −149.6 | −147.7 | 0.34 |
| YAP1 SRX1038945 | IMR-90 Lung | 269 / 16608 (1.6%) | 9632 / 166080 (5.8%) | −149.6 | −147.7 | 0.28 |
| FOXA1 SRX3931031 | MCF-7 Breast | 154 / 16608 (0.9%) | 7515 / 166080 (4.5%) | −149.4 | −147.5 | 0.20 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 394 / 16608 (2.4%) | 11707 / 166080 (7.0%) | −149.3 | −147.5 | 0.34 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 479 / 16608 (2.9%) | 13037 / 166080 (7.8%) | −149.2 | −147.3 | 0.37 |
| SP1 SRX190269 | A549 Lung | 542 / 16608 (3.3%) | 13991 / 166080 (8.4%) | −149.1 | −147.2 | 0.39 |
| ESR1 SRX10365558 | MCF-7 Breast | 238 / 16608 (1.4%) | 9072 / 166080 (5.5%) | −149.0 | −147.2 | 0.26 |
| ARID1A SRX5089388 | MCF-7 Breast | 169 / 16608 (1.0%) | 7792 / 166080 (4.7%) | −148.8 | −146.9 | 0.22 |
| CEBPB SRX190345 | MCF-7 Breast | 278 / 16608 (1.7%) | 9761 / 166080 (5.9%) | −148.8 | −146.9 | 0.28 |
| ESR1 SRX8537723 | MCF-7 Breast | 286 / 16608 (1.7%) | 9898 / 166080 (6.0%) | −148.8 | −146.9 | 0.29 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 497 / 16608 (3.0%) | 13294 / 166080 (8.0%) | −148.7 | −146.8 | 0.37 |
| AR SRX9109110 | MDA-MB-453 Breast | 701 / 16608 (4.2%) | 16315 / 166080 (9.8%) | −148.7 | −146.8 | 0.43 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 259 / 16608 (1.6%) | 9427 / 166080 (5.7%) | −148.5 | −146.7 | 0.27 |
| ESR1 SRX330068 | MCF-7 Breast | 155 / 16608 (0.9%) | 7508 / 166080 (4.5%) | −148.5 | −146.7 | 0.21 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 245 / 16608 (1.5%) | 9180 / 166080 (5.5%) | −148.5 | −146.6 | 0.27 |
| SREBF2 SRX5359049 | HCC70 Breast | 1155 / 16608 (7.0%) | 4588 / 166080 (2.8%) | −148.3 | −146.4 | 2.52 |
| EP300 SRX717859 | HeLa Uterus | 180 / 16608 (1.1%) | 7983 / 166080 (4.8%) | −148.3 | −146.4 | 0.23 |
| NR3C1 SRX10976921 | A549 Lung | 250 / 16608 (1.5%) | 9256 / 166080 (5.6%) | −148.1 | −146.2 | 0.27 |
| CEBPA SRX4705113 | MOLM-13 Blood | 858 / 16608 (5.2%) | 18493 / 166080 (11.1%) | −147.8 | −146.0 | 0.46 |
| ESR1 SRX5323873 | MCF-7 Breast | 456 / 16608 (2.7%) | 12626 / 166080 (7.6%) | −147.8 | −145.9 | 0.36 |
| FOXA1 SRX15431000 | T-47D Breast | 292 / 16608 (1.8%) | 9967 / 166080 (6.0%) | −147.7 | −145.9 | 0.29 |
| ZEB1 SRX13298924 | MCF-7 Breast | 160 / 16608 (1.0%) | 7582 / 166080 (4.6%) | −147.7 | −145.9 | 0.21 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 167 / 16608 (1.0%) | 7705 / 166080 (4.6%) | −147.3 | −145.5 | 0.22 |
| NANOG SRX10445309 | Neural crest cells Neural | 191 / 16608 (1.2%) | 8156 / 166080 (4.9%) | −147.0 | −145.2 | 0.23 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 732 / 16608 (4.4%) | 16682 / 166080 (10.0%) | −146.8 | −145.0 | 0.44 |
| RNF2 SRX18954719 | SCC-25 Others | 507 / 16608 (3.1%) | 13381 / 166080 (8.1%) | −146.8 | −145.0 | 0.38 |
| ZEB1 SRX13298923 | MCF-7 Breast | 138 / 16608 (0.8%) | 7118 / 166080 (4.3%) | −146.7 | −144.9 | 0.19 |
| TLE3 SRX4815194 | SUM 149PT Breast | 277 / 16608 (1.7%) | 9677 / 166080 (5.8%) | −146.7 | −144.8 | 0.29 |
| TP53 SRX19538272 | U2OS Bone | 518 / 16608 (3.1%) | 1111 / 166080 (0.7%) | −146.6 | −144.8 | 4.66 |
| SMARCA4 SRX5982341 | A549 Lung | 92 / 16608 (0.6%) | 6149 / 166080 (3.7%) | −146.5 | −144.7 | 0.15 |
| FOXA1 SRX5323846 | MCF-7 Breast | 119 / 16608 (0.7%) | 6725 / 166080 (4.0%) | −146.5 | −144.7 | 0.18 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1366 / 16608 (8.2%) | 5985 / 166080 (3.6%) | −146.5 | −144.7 | 2.28 |
| HOXC5 SRX2731653 | PC-3 Prostate | 287 / 16608 (1.7%) | 9841 / 166080 (5.9%) | −146.4 | −144.6 | 0.29 |
| WWTR1 SRX10119378 | MCF 10A Breast | 404 / 16608 (2.4%) | 11763 / 166080 (7.1%) | −146.4 | −144.6 | 0.34 |
| AR SRX10820651 | LNCAP Prostate | 317 / 16608 (1.9%) | 351 / 166080 (0.2%) | −146.3 | −144.5 | 9.03 |
| ESR1 SRX792933 | LY2 Breast | 291 / 16608 (1.8%) | 9906 / 166080 (6.0%) | −146.3 | −144.5 | 0.29 |
| RELA SRX7054618 | HAEC Cardiovascular | 367 / 16608 (2.2%) | 11153 / 166080 (6.7%) | −145.9 | −144.1 | 0.33 |
| FOXA1 SRX3923511 | MCF-7 Breast | 122 / 16608 (0.7%) | 6762 / 166080 (4.1%) | −145.6 | −143.8 | 0.18 |
| TFAP2C SRX018833 | MCF-7 Breast | 335 / 16608 (2.0%) | 10616 / 166080 (6.4%) | −145.6 | −143.8 | 0.32 |
| NR3C1 SRX19024870 | MCF-7 Breast | 103 / 16608 (0.6%) | 6352 / 166080 (3.8%) | −145.3 | −143.5 | 0.16 |
| FOXA1 SRX2642368 | VCaP Prostate | 457 / 16608 (2.8%) | 12548 / 166080 (7.6%) | −145.1 | −143.3 | 0.36 |
| JUN SRX7277180 | GM07492 Others | 312 / 16608 (1.9%) | 10214 / 166080 (6.2%) | −145.0 | −143.2 | 0.31 |
| FOXA1 SRX6441748 | CFPAC-1 Pancreas | 110 / 16608 (0.7%) | 6496 / 166080 (3.9%) | −145.0 | −143.2 | 0.17 |
Showing first 500 of 17919 rows.